RMD Insider Trading

Insider Ownership Percentage: 0.71%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $50,182,791.64

ResMed Insider Trading History Chart

This chart shows the insider buying and selling history at ResMed by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$454ksoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$20M-$10M$0$10M$20MTotal Insider BuyingTotal Insider Selling

ResMed Share Price & Price History

Current Price: $204.72
Price Change: Price Decrease of -8.631 (-4.05%)
As of 04/4/2025 04:59 PM ET

This chart shows the closing price history over time for RMD up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMarApr$204.72Closing price on 04/05/25:

SEC Filings (Institutional Ownership Changes) for ResMed (NYSE:RMD)

54.98% of ResMed stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at RMD by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$698kbought$1.08MsoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$1B$0$1BTotal InflowsTotal Outflows
ResMed logo
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Read More on ResMed

Today's Range

Now: $204.72
Low: $204.51
High: $211.55

50 Day Range

MA: $230.74
Low: $204.72
High: $257.63

52 Week Range

Now: $204.72
Low: $172.19
High: $263.05

Volume

2,065,584 shs

Average Volume

1,004,951 shs

Market Capitalization

$30.07 billion

P/E Ratio

24.17

Dividend Yield

0.95%

Beta

0.74

Who are the company insiders with the largest holdings of ResMed?

ResMed's top insider investors include:
  1. Michael J Farrell (CEO)
  2. Robert Andrew Douglas (COO)
  3. Peter C Farrell (Director)
  4. Brett Sandercock (CFO)
  5. David Pendarvis (Insider)
  6. Kaushik Ghoshal (Insider)
  7. Justin Leong (Insider)
  8. Michael J Rider (General Counsel)
  9. Karen Drexler (Director)
  10. Witte Jan De (Director)
Learn More about top insider investors at ResMed.

Who are the major institutional investors of ResMed?

ResMed's top institutional shareholders include:
  1. Confluence Investment Management LLC — 0.08%
  2. MassMutual Private Wealth & Trust FSB — 0.05%
  3. First Hawaiian Bank — 0.01%
  4. Versant Capital Management Inc — 0.00%
  5. Central Pacific Bank Trust Division — 0.00%
Learn More about top institutional investors of ResMed stock.

Which institutional investors are selling ResMed stock?

Within the last quarter, RMD stock was sold by these institutional investors:
  1. Confluence Investment Management LLC
  2. First Hawaiian Bank
Within the last year, company insiders that have sold ResMed company stock include:
  1. Michael J Farrell (CEO)
  2. Robert Andrew Douglas (COO)
  3. Peter C Farrell (Director)
  4. Brett Sandercock (CFO)
  5. David Pendarvis (Insider)
  6. Kaushik Ghoshal (Insider)
  7. Justin Leong (Insider)
  8. Michael J Rider (General Counsel)
Learn More investors selling ResMed stock.

Which institutional investors are buying ResMed stock?

During the last quarter, RMD stock was purchased by institutional investors including:
  1. MassMutual Private Wealth & Trust FSB
  2. Versant Capital Management Inc
  3. Central Pacific Bank Trust Division